These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. LPS exacerbates endothelin-1 induced activation of cytosolic phospholipase A2 and thromboxane A2 production from Kupffer cells of the prefibrotic rat liver. Miller AM, Masrorpour M, Klaus C, Zhang JX. J Hepatol; 2007 Feb; 46(2):276-85. PubMed ID: 17161492 [Abstract] [Full Text] [Related]
3. Role of thromboxane A2 in early BDL-induced portal hypertension. Yokoyama Y, Xu H, Kresge N, Keller S, Sarmadi AH, Baveja R, Clemens MG, Zhang JX. Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G453-60. PubMed ID: 12431905 [Abstract] [Full Text] [Related]
4. Endothelin-1-induced release of thromboxane A2 increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts. Zaugg CE, Hornstein PS, Zhu P, Simper D, Lüscher TF, Allegrini PR, Buser PT. Circulation; 1996 Aug 15; 94(4):742-7. PubMed ID: 8772697 [Abstract] [Full Text] [Related]
9. Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis. Yang YY, Huang YT, Tsai TH, Hou MC, Lee FY, Lee SD, Lin HC. Clin Sci (Lond); 2012 Dec 15; 123(12):669-80. PubMed ID: 22734967 [Abstract] [Full Text] [Related]
10. Kupffer cell activation by hydrogen peroxide: a new mechanism of portal pressure increase. Steib CJ, Bilzer M, Härtl JM, Beitinger F, Gülberg V, Göke B, Gerbes AL. Shock; 2010 Apr 15; 33(4):412-8. PubMed ID: 20118678 [Abstract] [Full Text] [Related]
11. Hydrogen sulfide modulates sinusoidal constriction and contributes to hepatic microcirculatory dysfunction during endotoxemia. Norris EJ, Feilen N, Nguyen NH, Culberson CR, Shin MC, Fish M, Clemens MG. Am J Physiol Gastrointest Liver Physiol; 2013 Jun 15; 304(12):G1070-8. PubMed ID: 23518685 [Abstract] [Full Text] [Related]
12. Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist. Nichols WW, Mehta J, Wargovich TJ, Franzini D, Lawson D. Angiology; 1989 Mar 15; 40(3):209-21. PubMed ID: 2537051 [Abstract] [Full Text] [Related]